Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.

Authors

Shuo Yang, Yibing Hou, Xiaohui Wang, Shuo Kang, Zhenhua Pan

Published in

PloS one. Volume 21. Issue 7. Pages e0353864. Epub Jul 14, 2026.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0351029.].

PMID:
42447108
Bibliographic data and abstract were imported from PubMed on 15 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.